QQ客服 官方微博 反馈留言

	Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis
	Wang, Peng-Cheng; Hu, Zhi-Qiang; Zhou, Shao-Lai; Zhan, Hao; Zhou, Zheng-Jun; Luo, Chu-Bin; Huang, Xiao-Wu
刊名	FUTURE ONCOLOGY
	2018
卷号	14期号:12
关键词	hepatocellular carcinoma MAGEH1 prognosis
ISSN号	1479-6694
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609356
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Peng-Cheng,Hu, Zhi-Qiang,Zhou, Shao-Lai,et al. Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis[J]. FUTURE ONCOLOGY,2018,14(12).
APA	Wang, Peng-Cheng.,Hu, Zhi-Qiang.,Zhou, Shao-Lai.,Zhan, Hao.,Zhou, Zheng-Jun.,...&Huang, Xiao-Wu.(2018).Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis.FUTURE ONCOLOGY,14(12).
MLA	Wang, Peng-Cheng,et al."Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis".FUTURE ONCOLOGY 14.12(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。